منابع مشابه
Glucose intolerance and its relation to cardiovascular risk factors among Greenland Inuit. The Greenland Population Study.
Tidligere har det været en generel opfattelse at forekomsten af type 2 diabetes var lav blandt grønlændere, men nyere studier fra Canada og Alaska har vist, at diabetes er tiltagende hyppigt forekommende hos inuit. Dette var baggrunden for at påbegynde befolkningsundersøgelsen i Grønland, B99, som var den første undersøgelse, hvor alle deltagere blev undersøgt ved hjælp af en oral glukose-belas...
متن کاملÜbersicht HRV – Diabetes II und Diabetes I
Lanza GA, Pitocco D, Navarese EP, Sestito A, Sgueglia GA, Manto A, Infusino F, Musella T, Ghirlanda G, Crea F. Istituto di Cardiologia, Università Cattolica del Sacro Cuore, Largo A. Gemelli, 8, 00168 Roma, Italy. [email protected] AIMS: To assess the relationship between cardiac autonomic dysfunction and inflammation in patients with type 1 diabetes and whether beta-blocker therapy might imp...
متن کاملDiabetes as autoimmune disease - Diabetes type I
Type 1 diabetes mellitus (T1D), also known as insulin dependent diabetes mellitus, is a chronic immune mediated disease that is characterized by selective loss of insulin producing β cells of the pancreatic islets in genetically susceptible subjects . The majority (95%) of cases are attributable to an autoimmune-mediated destruction of β cells (type 1a) while a small minority (5%) of cases resu...
متن کاملI. Identification of Chemical Diabetes
The natural history of diabetes mellitus can be arbitrarily divided into four stages based on the presence or absence of abnormal carbohydrate metabolism. Overt diabetes is the most advanced stage, characterized by elevated fasting blood glucose concentration and classical symptoms. This stage is divided into ketotic and nonketotic forms. Preceding overt diabetes is the latent or chemical diabe...
متن کاملImmunotherapy of type I diabetes.
A recent NIH panel in which I participated unanimously agreed that wide clinical application of immunotherapy for type I diabetes is at present inappropriate. The risks of premature application of such therapy outweigh potential benefits. In this editorial, I will briefly review the current information upon which I and my colleagues have begun small research trials of immunotherapy which 1 beli...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Tidsskrift for Den norske legeforening
سال: 2020
ISSN: 0029-2001
DOI: 10.4045/tidsskr.20.0849